CUSIP H0036K147SHSADCTQ4 2025
40 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Redmile Group, LLC | 15.67M | $55.30M |
| 2 | Tcg Crossover Management, LLC | 11.39M | $40.21M |
| 3 | Prosight Management, LP | 8.48M | $29.93M |
| 4 | Orbimed Advisors LLC | 5.82M | $20.55M |
| 5 | Nantahala Capital Management, LLC | 5.48M | $19.33M |
| 6 | Blackrock, Inc. | 5.43M | $19.16M |
| 7 | Point72 Asset Management, L.P. | 5.01M | $17.70M |
| 8 | Morgan Stanley | 3.77M | $13.31M |
| 9 |
| 4 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 4.0% | 5.01M | SEC |
| 5 | Feb 13, 2026 | Prosight Management, LP | 13G/A | 11.0% | 8.48M | SEC |
| 6 | Nov 13, 2025 | Prosight Management, LP | 13G/A | 11.0% | 7.20M | SEC |
| 7 | Nov 5, 2025 | Oaktree Fund Administration, LLC | 13G/A | 11.0% | 4.67M | SEC |
| 8 | Aug 14, 2025 | Redmile Group, LLC | 13G/A | 14.0% | 15.67M | SEC |
| 9 | Jun 17, 2025 | Point72 Asset Management, L.P. | 13G | 7.0% | 7.83M | SEC |
| 10 | May 19, 2025 | Hpwh Th AG | 13G/A | 9.6% | 9.79M | SEC |
See the full Schedule 13D/13G history for Adc Therapeutics SA.
Unlock full history| Eventide Asset Management, LLC |
| 3.36M |
| $11.88M |
| 10 | Goldman Sachs Group Inc | 1.64M | $5.79M |